Study to Characterize the Distribution of Lipoprotein (a) Levels Among Patients with Documented History of Atherosclerotic Cardiovascular Disease (ASCVD)

Brief description of study

This study is being done to learn more about Lipoprotein(a) values in people with known history of Atherosclerotic Cardiovascular Disease (ASCVD). The study is being done to identify the people with history of myocardial infarction (MI) and/or percutaneous coronary intervention (PCI) that have an Lp(a) level of at least 90 mg/dL or 200 nmol/L. Lipoprotein(a) is a particle that carries cholesterol in the blood and is a known risk factor for cardiovascular disease (CVD). High levels of Lp(a) are directly associated with a higher risk of cardiovascular events such as heart attacks or aortic stenosis. No study drug is being tested in this study. This study is only to learn about the distribution of Lp(a) in people with ASCVD. The total study duration for individual people will be approximately 2 weeks. Eligible participants will be paid $45.00 per completed on-site visit.

Eligibility of study

You may be eligible for this study if you meet the following criteria:

Conditions:
Cardiovascular Disease, Atherosclerotic Cardiovascular Disease, ASCVD
Age: Between 18 Years - 85 Years
Gender: All

Updated on 09 Mar 2024. Study ID: 851333

You have contacted , on

Your message has been sent to the study team at ,

A copy of the message has been sent to your email

What happens next?

You can expect the study team to contact you via email or phone in the next few days.
Sign up as volunteer to help accelerate the development of new treatments and to get notified about similar trials.

You are contacting

By sending a message, I agree that my data will be sent to a representative for the selected site and processed in accordance with this website's Privacy Policy (see link in footer).